ARIA. ARIAD Presents Initial Clinical Proof-of-Concept of AP26113 in Patients with Non-Small Cell Lung Cancer at ESMO 2012 Congress ~ First evidence of clinical anti-tumor activity in patients resistant to ALK or EGFR inhibitor therapy http://finance.yahoo.com/news/ariad-presents-initial-clinical-proof-091500610.html stockcharts.com/c-sc/sc?s=ARIA&p=W&yr=1&mn=0&dy=0&i=t46221611042&r=1348947543549